Difference between revisions of "Advanced Tissue Sciences"

From IntactiWiki
Jump to navigation Jump to search
m
m
Line 1: Line 1:
 
<!-- [[Image:Advanced Tissue Sciences.jpg|right|thumb|]] -->
 
<!-- [[Image:Advanced Tissue Sciences.jpg|right|thumb|]] -->
'''Advanced Tissue Sciences''' is a corporation based in La Jolla, CA. They are the makers of [[Dermagraft-TC]], which is an artifical skin created from harvested foreskins from infant circumcision.<ref name='Advanced Biohealing, 2010'>{{REFwebQuote
+
'''Advanced Tissue Sciences''' is a corporation based in La Jolla, CA. They are the makers of [[Dermagraft-TC]], which is an artifical skin created from harvested foreskins from infant circumcision.<ref name='Advanced Biohealing, 2010'>{{REFweb
 
  | quote=Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue.
 
  | quote=Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue.
 
  | last=
 
  | last=
Line 6: Line 6:
 
  | publisher=Advanced Biohealing, Inc.
 
  | publisher=Advanced Biohealing, Inc.
 
  | year=
 
  | year=
  | urltitle=Dermagraft-TC: Overview
+
  | title=Dermagraft-TC: Overview
 
  | url=http://www.dermagraft.com/about/overview/
 
  | url=http://www.dermagraft.com/about/overview/
 
  | accessdate=2011-03-06
 
  | accessdate=2011-03-06
}}</ref> They are also the makers of [[NouriCel]], another product made from harvested foreskins,<ref name='Acroposthion 2011'>{{ REFwebQuote
+
}}</ref> They are also the makers of [[NouriCel]], another product made from harvested foreskins,<ref name='Acroposthion 2011'>{{ REFweb
 
  | quote=TNS contains... NouriCel-MD which is... a combination of Natural Growth Factors, matrix proteins, and soluble collagen. Human Growth Factors extracted from cultured cells of foreskin...
 
  | quote=TNS contains... NouriCel-MD which is... a combination of Natural Growth Factors, matrix proteins, and soluble collagen. Human Growth Factors extracted from cultured cells of foreskin...
 
  | last=
 
  | last=
Line 15: Line 15:
 
  | publisher=Acroposthion.com
 
  | publisher=Acroposthion.com
 
  | year=
 
  | year=
  | urltitle=The Foreskin Mafia
+
  | title=The Foreskin Mafia
 
  | url=http://www.acroposthion.com/acroposthion_019.htm
 
  | url=http://www.acroposthion.com/acroposthion_019.htm
 
  | accessdate=2011-03-06
 
  | accessdate=2011-03-06
}}</ref> and one of the main ingredients of [[SkinMedica]]'s [[TNS Recovery Complex]] product.<ref name='SkinMedica 2011'>{{REFwebQuote
+
}}</ref> and one of the main ingredients of [[SkinMedica]]'s [[TNS Recovery Complex]] product.<ref name='SkinMedica 2011'>{{REFweb
 
  | quote=TNS Recovery Complex is the only product containing a professional concentration of NouriCel®, a new cosmetic ingredient from leading tissue-engineering company Advanced Tissue Sciences.
 
  | quote=TNS Recovery Complex is the only product containing a professional concentration of NouriCel®, a new cosmetic ingredient from leading tissue-engineering company Advanced Tissue Sciences.
 
  | last=
 
  | last=
Line 24: Line 24:
 
  | publisher=SkinMedica
 
  | publisher=SkinMedica
 
  | year=2002-02-12
 
  | year=2002-02-12
  | urltitle=SkinMedica Introduces TNS Recovery Complex
+
  | title=SkinMedica Introduces TNS Recovery Complex
 
  | url=http://www.corporate.skinmedica.com/press/2002/skinmedica-launches-tns-recovery-complex
 
  | url=http://www.corporate.skinmedica.com/press/2002/skinmedica-launches-tns-recovery-complex
 
  | accessdate=2011-03-06
 
  | accessdate=2011-03-06
Line 31: Line 31:
 
== Earnings ==
 
== Earnings ==
  
Dermagraft-TC is FDA approved,<ref>{{REFwebQuote
+
Dermagraft-TC is FDA approved,<ref>{{REFweb
 
  | quote=Dermagraft-TC is the first human, fibroblast-derived temporary skin substitute for the treatment of partial-thickness burns that has been approved for marketing by the FDA.
 
  | quote=Dermagraft-TC is the first human, fibroblast-derived temporary skin substitute for the treatment of partial-thickness burns that has been approved for marketing by the FDA.
 
  | last=
 
  | last=
 
  | first=
 
  | first=
 
  | publisher=MediLexicon International Ltd
 
  | publisher=MediLexicon International Ltd
  | year=2011
+
  | date=2011
  | urltitle=Dermagraft-TC: General Information: Advanced Tissue Sciences
+
  | title=Dermagraft-TC: General Information: Advanced Tissue Sciences
 
  | url=http://www.medilexicon.com/drugs/dermagraft-tc.php#GeneralInformation
 
  | url=http://www.medilexicon.com/drugs/dermagraft-tc.php#GeneralInformation
 
  | accessdate=2011-05-07
 
  | accessdate=2011-05-07
}}</ref><ref>{{REFwebQuote
+
}}</ref><ref>{{REFweb
 
  | quote=the Food and Drug Administration has approved Dermagraft-TC
 
  | quote=the Food and Drug Administration has approved Dermagraft-TC
 
  | last=
 
  | last=
 
  | first=
 
  | first=
 
  | publisher=HighBeam Research
 
  | publisher=HighBeam Research
  | year=1997-03-28
+
  | date=1997-03-28
  | urltitle= Transplant News: Advanced Tissue Sciences' temporary wound covering Dermagraft-TC approved for marketing by FDA
+
  | title= Transplant News: Advanced Tissue Sciences' temporary wound covering Dermagraft-TC approved for marketing by FDA
 
  | url=http://www.highbeam.com/doc/1G1-47248437.html
 
  | url=http://www.highbeam.com/doc/1G1-47248437.html
 
  | accessdate=2011-05-07
 
  | accessdate=2011-05-07
Line 54: Line 54:
 
  | last=Pitta
 
  | last=Pitta
 
  | first=Julie
 
  | first=Julie
  | year=10 May 1993
+
  | date=10 May 1993
 
  | title=Biosynthetics
 
  | title=Biosynthetics
 
  | url=
 
  | url=
Line 65: Line 65:
 
  | publisher=Forbes  
 
  | publisher=Forbes  
 
  | isbn=
 
  | isbn=
 +
| accessdate=
 
  | note=The 32-page Advanced Tissue Sciences, Inc. 1997 Annual Report refers to "fibroblasts" but does not contain the word "foreskin."
 
  | note=The 32-page Advanced Tissue Sciences, Inc. 1997 Annual Report refers to "fibroblasts" but does not contain the word "foreskin."
| accessdate=
 
 
}}</ref>
 
}}</ref>
  

Revision as of 15:57, 21 August 2019

Advanced Tissue Sciences is a corporation based in La Jolla, CA. They are the makers of Dermagraft-TC, which is an artifical skin created from harvested foreskins from infant circumcision.[1] They are also the makers of NouriCel, another product made from harvested foreskins,[2] and one of the main ingredients of SkinMedica's TNS Recovery Complex product.[3]

Earnings

Dermagraft-TC is FDA approved,[4][5] and it sells for about $3,000 per square foot and one foreskin contains enough genetic material to grow 250,000 square feet of skin.[6]

Advanced Tissue Sciences has sold about $1 million worth of cultured dermis to Proctor & Gamble, Helene Curtis, and other such businesses for pre-market testing. Advanced Tissue Science's foreskin-derived merchandise held a $32 million stock offering in the beginning of 1992.[7]

In 1996 alone, Advanced Tissue Sciences could boast of a healthy $663.9 million market capitalization performance.[8]

References

  1. REFweb Dermagraft-TC: Overview, Advanced Biohealing, Inc.. Retrieved 6 March 2011.
    Quote: Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue.
  2. REFweb The Foreskin Mafia, Acroposthion.com. Retrieved 6 March 2011.
    Quote: TNS contains... NouriCel-MD which is... a combination of Natural Growth Factors, matrix proteins, and soluble collagen. Human Growth Factors extracted from cultured cells of foreskin...
  3. REFweb SkinMedica Introduces TNS Recovery Complex, SkinMedica. Retrieved 6 March 2011.
    Quote: TNS Recovery Complex is the only product containing a professional concentration of NouriCel®, a new cosmetic ingredient from leading tissue-engineering company Advanced Tissue Sciences.
  4. REFweb (2011). Dermagraft-TC: General Information: Advanced Tissue Sciences, MediLexicon International Ltd. Retrieved 7 May 2011.
    Quote: Dermagraft-TC is the first human, fibroblast-derived temporary skin substitute for the treatment of partial-thickness burns that has been approved for marketing by the FDA.
  5. REFweb (28 March 1997). Transplant News: Advanced Tissue Sciences' temporary wound covering Dermagraft-TC approved for marketing by FDA, HighBeam Research. Retrieved 7 May 2011.
    Quote: the Food and Drug Administration has approved Dermagraft-TC
  6. Circumcision. Daecher M. Icon 1998;2(2):70-3.
  7. REFbook Pitta, Julie: Biosynthetics. Forbes. Pp. 170-171.
    Note: The 32-page Advanced Tissue Sciences, Inc. 1997 Annual Report refers to "fibroblasts" but does not contain the word "foreskin."
  8. Biotech's Big Discovery. Hall CT. San Francisco Chronicle. October 25, 1996: E1, E4.